Correlation Between Molecular Partners and Nuvation Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Molecular Partners and Nuvation Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and Nuvation Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Partners AG and Nuvation Bio, you can compare the effects of market volatilities on Molecular Partners and Nuvation Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of Nuvation Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and Nuvation Bio.

Diversification Opportunities for Molecular Partners and Nuvation Bio

0.19
  Correlation Coefficient

Average diversification

The 3 months correlation between Molecular and Nuvation is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and Nuvation Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvation Bio and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with Nuvation Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvation Bio has no effect on the direction of Molecular Partners i.e., Molecular Partners and Nuvation Bio go up and down completely randomly.

Pair Corralation between Molecular Partners and Nuvation Bio

Given the investment horizon of 90 days Molecular Partners is expected to generate 2.04 times less return on investment than Nuvation Bio. In addition to that, Molecular Partners is 1.21 times more volatile than Nuvation Bio. It trades about 0.02 of its total potential returns per unit of risk. Nuvation Bio is currently generating about 0.05 per unit of volatility. If you would invest  170.00  in Nuvation Bio on September 1, 2024 and sell it today you would earn a total of  120.00  from holding Nuvation Bio or generate 70.59% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Molecular Partners AG  vs.  Nuvation Bio

 Performance 
       Timeline  
Molecular Partners 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Molecular Partners AG are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain essential indicators, Molecular Partners displayed solid returns over the last few months and may actually be approaching a breakup point.
Nuvation Bio 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Nuvation Bio are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Nuvation Bio is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Molecular Partners and Nuvation Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Molecular Partners and Nuvation Bio

The main advantage of trading using opposite Molecular Partners and Nuvation Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, Nuvation Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvation Bio will offset losses from the drop in Nuvation Bio's long position.
The idea behind Molecular Partners AG and Nuvation Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Bonds Directory
Find actively traded corporate debentures issued by US companies